Top

Published in:

Open Access 01-03-2021 | Breast Cancer | Original Article

Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients

Authors: L. Vehmanen, H. Sievänen, P. Kellokumpu-Lehtinen, R. Nikander, R. Huovinen, J. Ruohola, H.M. Penttinen, M. Utriainen, K. Tokola, C. Blomqvist, T. Saarto

Published in: Osteoporosis International | Issue 3/2021

Abstract

Summary

A 12-month exercise program reversibly prevented hip bone loss in premenopausal women with early breast cancer. The bone-protective effect was maintained for 2 years after the end of the program but was lost thereafter.

Purpose

Breast cancer survivors are at an increased risk for osteoporosis and fracture. This 5-year follow-up of a randomized impact exercise intervention trial evaluated the maintenance of training effects on bone among breast cancer patients.

Methods

Five hundred seventy-three early breast cancer patients aged 35–68 years and treated with adjuvant therapy were allocated into a 12-month exercise program or a control group. Four hundred forty-four patients (77%) were included in the 5-year analysis. The exercise intervention comprised weekly supervised step aerobics, circuit exercises, and home training. Areal bone mineral density (aBMD) was measured by dual-energy X-ray absorptiometry. Physical activity was estimated in metabolic equivalent (MET) hours per week and physical performance assessed by 2-km walking and figure-8 running tests.

Results

In premenopausal patients, the 12-month exercise program maintained femoral neck (FN) and total hip (TH) aBMD for 3 years, but the protective effect was lost thereafter. The mean FN aBMD change in the exercise and control groups was − 0.2% and − 1.5% 1 year, − 1.1% and − 2.1% 3 years and − 3.3% versus − 2.4% 5 years after the beginning of the intervention, respectively. Lumbar spine (LS) bone loss was not prevented in premenopausal women and no training effects on aBMD were seen in postmenopausal women. The main confounding element of the study was the unexpected rise in physical activity among patients in the control group. The physical performance improved among premenopausal women in the exercise group compared with the controls.

Conclusion

The 12-month exercise program prevented FN and TH bone loss in premenopausal breast cancer patients for 3 years. The bone-protective effect was reversible and lost thereafter.

Available only for authorised users

Hajdi P, Aapro M, Body J et al (2017) Management of aromatase inhibitor associated bone loss (AIBL) in postmenopausal women with hormone sensitive breast cancer. Joint position statement of IOF, CABS, ECTS, IEG, ESCEO, IMS and SIOG. J Bone Oncol 7:1–12. https://doi.org/10.1016/j.jbo.2017.03.001CrossRef

Chen Z, Maricic M, Bassford TL, Pettinger M, Ritenbaugh C, Lopez AM, Barad DH, Gass M, Leboff MS (2005) Fracture risk among breast cancer survivors: results from the Women’s Health Initiative Observational Study. Arch Intern Med 165:552–558. https://doi.org/10.1001/archinte.165.5.552CrossRefPubMed

Shapiro CL, Manola J, Leboff M (2001) Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 19:3306–3311. https://doi.org/10.1200/JCO.2001.19.14.3306CrossRefPubMed

Saarto T, Blomqvist C, Välimäki M, Mäkelä P, Sarna S, Elomaa I (1997) Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol 15:1341–1347. https://doi.org/10.1200/JCO.1997.15.4.1341CrossRefPubMed

Perez E, Josse RG, Pritchard KI et al (2006) Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol 24:3629–3635. https://doi.org/10.1200/JCO.2005.05.4882CrossRefPubMed

Dhesy-Thind S, Fletcher G, Blanchette P et al (2017) Use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer: a Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 35:2062–2081. https://doi.org/10.1200/JCO.2016.70.7257CrossRefPubMed

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2015) Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomized trials. Lancet 386:1353–1361. https://doi.org/10.1016/S0140-6736(15)60908-4CrossRef

Saarto T, Penttinen HM, Sievänen H et al (2012) Effectiveness of a 12-month exercise program on physical performance and quality of life of breast cancer survivors. Anticancer Res 32:3875–3884PubMed

Loprinzi PD, Cardinal BJ (2012) Effects of physical activity on common side effects of breast cancer treatment. Breast Cancer 19:4–10. https://doi.org/10.1007/s12282-011-0292-3CrossRefPubMed

10.

Schmid D, Leitzmann MF (2014) Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol 25:1293–1311. https://doi.org/10.1093/annonc/mdu012CrossRefPubMed

11.

Wolff I, van Croonenborg JJ, Kemper HC et al (1999) The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 9:1–12. https://doi.org/10.1007/s001980050109CrossRefPubMed

12.

Kelley GA, Kelley KS, Kohrt WM (2013) Exercise and bone mineral density in premenopausal women: a meta-analysis of randomized controlled trials. Int J Endocrinol 2013:741–639. https://doi.org/10.1155/2013/741639CrossRef

13.

Zhao R, Zhao M, Xu Z (2015) The effects of differing resistance training modes on the preservation of bone mineral density in postmenopausal women: a meta-analysis. Osteoporos Int 26:1605–1618. https://doi.org/10.1007/s00198-015-3034-0CrossRefPubMed

14.

Nikander R, Sievänen H, Heinonen A, Daly RM, Uusi-Rasi K, Kannus P (2010) Targeted exercise against osteoporosis: a systematic review and meta-analysis for optimising bone strength throughout life. BMC Med 8:47. https://doi.org/10.1186/1741-7015-8-47CrossRefPubMedPubMedCentral

15.

Thomas GA, Cartmel B, Harrigan M, Fiellin M, Capozza S, Zhou Y, Ercolano E, Gross CP, Hershman D, Ligibel J, Schmitz K, Li FY, Sanft T, Irwin ML (2017) The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity 25:346–351. https://doi.org/10.1002/oby.21729CrossRefPubMed

16.

Kim SH, Cho YU, Kim SJ, Hong S, Han MS, Choi E (2016) The effect on bone outcomes of adding exercise to supplements for osteopenic breast cancer survivors: a pilot randomized controlled trial. Cancer Nurs 39:144–152. https://doi.org/10.1097/NCC.0000000000000245CrossRefPubMed

17.

Knobf MT, Jeon S, Smith B, Harris L, Kerstetter J, Thompson AS, Insogna K (2016) Effect of a randomized controlled exercise trial on bone outcomes: influence of adjuvant endocrine therapy. Breast Cancer Res Treat 155:491–500. https://doi.org/10.1007/s10549-016-3693-3CrossRefPubMed

18.

Winters-Stone KM, Dobek J, Nail L, Bennett JA, Leo MC, Naik A, Schwartz A (2011) Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial. Breast Cancer Res Treat 127:447–456. https://doi.org/10.1007/s10549-011-1444-zCrossRefPubMedPubMedCentral

19.

Winters-Stone KM, Dobek J, Nail LM, Bennett JA, Leo MC, Torgrimson-Ojerio B, Luoh SW, Schwartz A (2013) Impact + resistance training improves bone health and body composition in prematurely menopausal breast cancer survivors: a randomized controlled trial. Osteoporos Int 24:1637–1646. https://doi.org/10.1007/s00198-012-2143-2CrossRefPubMed

20.

Winters-Stone KM, Laudermilk M, Woo K, Brown JC, Schmitz KH (2014) Influence of weight training on skeletal health of breast cancer survivors with or at risk for breast cancer-related lymphedema. J Cancer Surviv 8:260–268. https://doi.org/10.1007/s11764-013-0337-zCrossRefPubMedPubMedCentral

21.

Schwartz AL, Winters-Stone K, Gallucci B (2007) Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum 34:627–633. https://doi.org/10.1188/07.ONF.627-633CrossRefPubMed

22.

Waltman NL, Twiss JJ, Ott CD, Gross GJ, Lindsey AM, Moore TE, Berg K, Kupzyk K (2010) The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial. Osteoporos Int 21:1361–1369. https://doi.org/10.1007/s00198-009-1083-yCrossRefPubMed

23.

Irwin ML, Alvarez-Reeves M, Cadmus L, Mierzejewski E, Mayne ST, Yu H, Chung GG, Jones B, Knobf MT, DiPietro L (2009) Exercise improves body fat, lean mass, and bone mass in breast cancer survivors. Obesity 17:1534–1541. https://doi.org/10.1038/oby.2009.18CrossRefPubMed

24.

Saarto T, Sievänen H, Kellokumpu-Lehtinen P, Nikander R, Vehmanen L, Huovinen R, Kautiainen H, Järvenpää S, Penttinen HM, Utriainen M, Jääskeläinen AS, Elme A, Ruohola J, Palva T, Vertio H, Rautalahti M, Fogelholm M, Luoto R, Blomqvist C (2012) Effect of supervised and home exercise training on bone mineral density among breast cancer patients. A 12-month randomized controlled trial. Osteoporos Int 23:1601–1612. https://doi.org/10.1007/s00198-011-1761-4CrossRefPubMed

25.

Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:498–504. https://doi.org/10.1097/00005768-200009001-00009CrossRef

26.

Oja P, Laukkanen R, Pasanen M, Tyry T, Vuori I (1991) A 2-km walking test for assessing the cardiorespiratory fitness of healthy adults. Int J Sports Med 12:356–362. https://doi.org/10.1055/s-2007-1024694CrossRefPubMed

27.

Tegner Y, Lysholm J, Lysholm M, Gillquist J (1986) A performance test to monitor rehabilitation and evaluate anterior cruciate ligament injuries. Am J Sports Med 14:156–159. https://doi.org/10.1177/036354658601400212CrossRefPubMed

28.

Bassey E, Rothwell M, Littlewood J, Pye D (1998) Pre- and postmenopausal women have different bone mineral density responses to the same high-impact exercise. J Bone Miner Res 13:1805–1813. https://doi.org/10.1359/jbmr.1998.13.12.1805CrossRefPubMed

29.

Sugiyama T, Yamaguchi A, Kawai S (2002) Effects of skeletal loading on bone mass and compensation mechanism in bone: a new insight into the B mechanostat theory. J Bone Miner Metab 20:196–200. https://doi.org/10.1007/s007740200028CrossRefPubMed

30.

Dalla via J, Daly RM, Fraser SF (2018) The effect of exercise on bone mineral density in adult cancer survivors: a systematic review and meta-analysis. Osteoporosis Int 29:287–303. https://doi.org/10.1007/s00198-017-4237-3CrossRef

31.

Heinonen A, Kannus P, Sievänen H, Oja P, Pasanen M, Rinne M, Uusi-Rasi K, Vuori I (1996) Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet 348:1343–1347. https://doi.org/10.1016/S0140-6736(96)04214-6CrossRefPubMed

32.

Kontulainen S, Heinonen A, Kannus P et al (2004) Former exercisers of an 18-month intervention display residual aBMD benefits compared with control women 3.5 years post-intervention: a follow-up of a randomized controlled high-impact trial. Osteoporos Int 15:248–251. https://doi.org/10.1007/s00198-003-1559-0CrossRefPubMed

33.

Uusi-Rasi K, Kannus P, Cheng S, Sievänen H, Pasanen M, Heinonen A, Nenonen A, Halleen J, Fuerst T, Genant H, Vuori I (2003) Effect of alendronate and exercise on bone and physical performance of postmenopausal women: a randomized controlled trial. Bone 33:132–143. https://doi.org/10.1016/s8756-3282(03)00082-6CrossRefPubMed

34.

Coleman R, Collinson M, Gregory W et al (2018) Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04). Bone Oncol 13:123–135. https://doi.org/10.1016/j.jbo.2018.09.008CrossRef

35.

Willis B, Gao A, Leonard D et al (2012) Midlife fitness and the development of chronic conditions in later life. Arch Intern Med 172:1333–1340. https://doi.org/10.1001/archinternmed.2012.3400CrossRefPubMedPubMedCentral

36.

Piercy K, Troiano R, Ballard R et al (2018) The physical activity guidelines for Americans. JAMA 320:2020–2028. https://doi.org/10.1001/jama.2018.14854CrossRefPubMed

37.

Nikander R, Sievänen H, Ojala K, Oivanen T, Kellokumpu-Lehtinen PL, Saarto T (2007) Effect of a vigorous aerobic regimen on physical performance in breast cancer patients—a randomized controlled pilot trial. Acta Oncol 46:181–186. https://doi.org/10.1080/02841860600833145CrossRefPubMed

38.

Nikander R, Kannus P, Dastidar P et al (2009) Targeted exercises against hip fragility. Osteoporos Int 20:1321–1328. https://doi.org/10.1007/s00198-008-0785-xCrossRefPubMed

Title: Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients
Authors: L. Vehmanen
H. Sievänen
P. Kellokumpu-Lehtinen
R. Nikander
R. Huovinen
J. Ruohola
H.M. Penttinen
M. Utriainen
K. Tokola
C. Blomqvist
T. Saarto
Publication date: 01-03-2021
Publisher: Springer London
Keywords: Breast Cancer
Osteoporosis
Breast Cancer
Osteoporosis
Published in: Osteoporosis International / Issue 3/2021
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-020-05611-w

ACC 2024 Congress

Springer Medicine

Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients

Abstract

Summary

Purpose

Methods

Results

Conclusion

ACC 2024 Congress

Springer Medicine

Abstract

Summary

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2021

FRAX without BMD can be used to risk-stratify Veterans who recently sustained a low trauma non-vertebral/non-hip fracture

Incidence and circumstances of falls among middle-aged women: a cohort study

Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden

Functional electrical stimulation (FES)–assisted rowing combined with zoledronic acid, but not alone, preserves distal femur strength and stiffness in people with chronic spinal cord injury

Reference range for 24-h urine calcium, calcium/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women

Sleep duration and bone health measures in older men